Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 269 shares at $79.04 ($21K) on 2022-09-02, disclosed to the SEC on 2022-09-06.
Open-market sale of $21k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |